(Q39598073)

English

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

scientific article published on 26 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

anti-retroviral agent

0 references

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

A Winston

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

W Stöhr

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Antinori

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Arenas-Pinto

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J M Llibre

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

H Amieva

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

I Williams

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

G Di Perri

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

M J Tellez

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J Rockstroh

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Babiker

12

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Pozniak

13

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

F Raffi

14

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

L Richert

15

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group

16

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

471-478

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Cognitive disorders in HIV-infected patients: are they HIV-related?

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Screening for cognitive impairment in human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Neurocognitive function in HIV infected patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

The Relationship between Height and Cognitive Function among Community-dwelling Elderly: Hallym Aging Study

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12344

21 January 2018

Identifiers

10.1111/HIV.12344

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39598073&oldid=1843262176"